Carregant...
Beyond cardiovascular medicine: potential future uses of icosapent ethyl
The REDUCE-IT trial demonstrated that icosapent ethyl, an ethyl ester of eicosapentaenoic acid (EPA), reduced cardiovascular events in an at-risk population by a substantial degree. While the cardiovascular protective properties of this compound are now proven, several other potential uses are being...
Guardat en:
| Publicat a: | Eur Heart J Suppl |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537800/ https://ncbi.nlm.nih.gov/pubmed/33061868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa119 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|